-
1
-
-
37149026076
-
Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004
-
Wong ND, Lopez VA, L'Italien G, et al. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med 2007;167:2431-2436
-
(2007)
Arch Intern Med
, vol.167
, pp. 2431-2436
-
-
Wong, N.D.1
Lopez, V.A.2
L'Italien, G.3
-
2
-
-
0025959101
-
An updated coronary risk profile. A statement for health professionals
-
Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-362
-
(1991)
Circulation
, vol.83
, pp. 356-362
-
-
Anderson, K.M.1
Wilson, P.W.2
Odell, P.M.3
Kannel, W.B.4
-
3
-
-
0035522330
-
Impact of high-normal blood pressure on the risk of cardiovascular disease
-
Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-1297
-
(2001)
N Engl J Med
, vol.345
, pp. 1291-1297
-
-
Vasan, R.S.1
Larson, M.G.2
Leip, E.P.3
-
4
-
-
0037079309
-
Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
-
Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913
-
(2002)
Lancet
, vol.360
, pp. 1903-1913
-
-
Lewington, S.1
Clarke, R.2
Qizilbash, N.3
-
5
-
-
0242654867
-
Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials
-
Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-1535
-
(2003)
Lancet
, vol.362
, pp. 1527-1535
-
-
Turnbull, F.1
-
6
-
-
33746797303
-
Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis
-
Sipahi I, Tuzcu EM, Schoenhagen P, et al. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol 2006;48:833-838
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 833-838
-
-
Sipahi, I.1
Tuzcu, E.M.2
Schoenhagen, P.3
-
7
-
-
33847633400
-
Prevalence awareness treatment and control of hypertension among United States adults 1999-2004
-
Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49:69-75
-
(2007)
Hypertension
, vol.49
, pp. 69-75
-
-
Ong, K.L.1
Cheung, B.M.2
Man, Y.B.3
-
8
-
-
69349103215
-
The hypertension paradox: More uncontrolled disease despite improved therapy
-
Shattuck Lecture
-
Chobanian AV. Shattuck Lecture. The hypertension paradox: more uncontrolled disease despite improved therapy. N Engl J Med 2009;361:878-887
-
(2009)
N Engl J Med
, vol.361
, pp. 878-887
-
-
Chobanian, A.V.1
-
9
-
-
73649132652
-
Reappraisal of European guidelines on hypertension management: A European Society of hypertension task force document
-
Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009;18:308-347
-
(2009)
Blood Press
, vol.18
, pp. 308-347
-
-
Mancia, G.1
Laurent, S.2
Agabiti-Rosei, E.3
-
10
-
-
77951735232
-
Effects of intensive blood-pressure control in type 2 diabetes mellitus
-
Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575-1585
-
(2010)
N Engl J Med
, vol.362
, pp. 1575-1585
-
-
Cushman, W.C.1
Evans, G.W.2
Byington, R.P.3
-
11
-
-
0347423198
-
Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
-
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-1252
-
(2003)
Hypertension
, vol.42
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
13
-
-
44149120305
-
It's time to overcome clinical inertia
-
Phillips LS, Twombly JG. It's time to overcome clinical inertia. Ann Intern Med 2008;148:783-785
-
(2008)
Ann Intern Med
, vol.148
, pp. 783-785
-
-
Phillips, L.S.1
Twombly, J.G.2
-
14
-
-
33644979283
-
Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals
-
Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 2006;47:345-351
-
(2006)
Hypertension
, vol.47
, pp. 345-351
-
-
Okonofua, E.C.1
Simpson, K.N.2
Jesri, A.3
-
15
-
-
57349138291
-
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
-
Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-2428
-
(2008)
N Engl J Med
, vol.359
, pp. 2417-2428
-
-
Jamerson, K.1
Weber, M.A.2
Bakris, G.L.3
-
16
-
-
58949098039
-
Blood pressure control by drug group in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
-
Cushman WC, Ford CE, Einhorn PT, et al. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich) 2008;10:751-760
-
(2008)
J Clin Hypertens (Greenwich)
, vol.10
, pp. 751-760
-
-
Cushman, W.C.1
Ford, C.E.2
Einhorn, P.T.3
-
17
-
-
33745987893
-
Valsartan, blood pressure reduction, and C-reactive protein: Primary report of the Val-MARC trial
-
Ridker PM, Danielson E, Rifai N, Glynn RJ. Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial. Hypertension 2006;48:73-79
-
(2006)
Hypertension
, vol.48
, pp. 73-79
-
-
Ridker, P.M.1
Danielson, E.2
Rifai, N.3
Glynn, R.J.4
-
18
-
-
47249088609
-
Efficacy and safety of amlodipine/ valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: A randomized, double-blind, multicenter study: The EX-EFFeCTS Study
-
Destro M, Luckow A, Samson M, et al. Efficacy and safety of amlodipine/ valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study. J Am Soc Hypertens 2008;2:294-302
-
(2008)
J Am Soc Hypertens
, vol.2
, pp. 294-302
-
-
Destro, M.1
Luckow, A.2
Samson, M.3
-
19
-
-
67649449128
-
Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: The EX-STAND study
-
Flack JM, Calhoun DA, Satlin L, et al. Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study. J Hum Hypertens 2009;23:479-489
-
(2009)
J Hum Hypertens
, vol.23
, pp. 479-489
-
-
Flack, J.M.1
Calhoun, D.A.2
Satlin, L.3
-
20
-
-
4644242120
-
The burden of adult hypertension in the United States 1999 to 2000: A rising tide
-
Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004;44:398-404
-
(2004)
Hypertension
, vol.44
, pp. 398-404
-
-
Fields, L.E.1
Burt, V.L.2
Cutler, J.A.3
-
21
-
-
0023727613
-
Age and blood pressure changes. A 20-year follow-up study in nuns in a secluded order
-
Timio M, Verdecchia P, Venanzi S, et al. Age and blood pressure changes. A 20-year follow-up study in nuns in a secluded order. Hypertension 1988;12:457-461
-
(1988)
Hypertension
, vol.12
, pp. 457-461
-
-
Timio, M.1
Verdecchia, P.2
Venanzi, S.3
-
22
-
-
2942635317
-
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial
-
Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022-2031
-
(2004)
Lancet
, vol.363
, pp. 2022-2031
-
-
Julius, S.1
Kjeldsen, S.E.2
Weber, M.3
-
23
-
-
2942695964
-
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial
-
Weber MA, Julius S, Kjeldsen SE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet 2004;363:2049-2051
-
(2004)
Lancet
, vol.363
, pp. 2049-2051
-
-
Weber, M.A.1
Julius, S.2
Kjeldsen, S.E.3
-
24
-
-
0037534905
-
The study on cognition and prognosis in the elderly (SCOPE): Principal results of a randomized double-blind intervention trial
-
DOI 10.1097/00004872-200305000-00011
-
Lithell H, Hansson L, Skoog I, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003;21:875-886 (Pubitemid 36677151)
-
(2003)
Journal of Hypertension
, vol.21
, Issue.5
, pp. 875-886
-
-
Lithell, H.1
Hansson, L.2
Skoog, I.3
Elmfeldt, D.4
Hofman, A.5
Olofsson, B.6
Trenkwalder, P.7
Zanchetti, A.8
-
25
-
-
11144356621
-
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial
-
Staessen JA, Thijisq L, Fagard R, et al. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens 2004;22:847-857
-
(2004)
J Hypertens
, vol.22
, pp. 847-857
-
-
Staessen, J.A.1
Thijisq, L.2
Fagard, R.3
-
26
-
-
58149399241
-
Does earlier attainment of blood pressure goal translate into fewer cardiovascular events?
-
Nasser SA, Lai Z, O'Connor S, et al. Does earlier attainment of blood pressure goal translate into fewer cardiovascular events? Curr Hypertens Rep 2008;10:398-404
-
(2008)
Curr Hypertens Rep
, vol.10
, pp. 398-404
-
-
Nasser, S.A.1
Lai, Z.2
O'Connor, S.3
-
27
-
-
18244395882
-
Early and aggressive treatment of complex hypertension
-
Mugo MN, Sowers JR. Early and aggressive treatment of complex hypertension. J Clin Hypertens (Greenwich) 2005;7:8-10
-
(2005)
J Clin Hypertens (Greenwich)
, vol.7
, pp. 8-10
-
-
Mugo, M.N.1
Sowers, J.R.2
-
28
-
-
0346102472
-
Hydrochlorothiazide versus chlorthalidone: Evidence supporting their interchangeability
-
Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004;43:4-9
-
(2004)
Hypertension
, vol.43
, pp. 4-9
-
-
Carter, B.L.1
Ernst, M.E.2
Cohen, J.D.3
-
29
-
-
52449097821
-
Should chlorthalidone be the diuretic of choice for antihypertensive therapy?
-
Taler SJ. Should chlorthalidone be the diuretic of choice for antihypertensive therapy? Curr Hypertens Rep 2008;10:293-297
-
(2008)
Curr Hypertens Rep
, vol.10
, pp. 293-297
-
-
Taler, S.J.1
-
30
-
-
33644981542
-
Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure
-
Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006;47:352-358
-
(2006)
Hypertension
, vol.47
, pp. 352-358
-
-
Ernst, M.E.1
Carter, B.L.2
Goerdt, C.J.3
-
31
-
-
58149457772
-
All thiazide-like diuretics are not chlorthalidone: Putting the ACCOMPLISH study into perspective
-
Ernst ME, Carter BL, Basile JN. All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective. J Clin Hypertens (Greenwich) 2009;11:5-10
-
(2009)
J Clin Hypertens (Greenwich)
, vol.11
, pp. 5-10
-
-
Ernst, M.E.1
Carter, B.L.2
Basile, J.N.3
-
32
-
-
34250350040
-
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
-
DOI 10.1097/HJH.0b013e3281fc975a, PII 0000487220070600000001
-
Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187 (Pubitemid 46924065)
-
(2007)
Journal of Hypertension
, vol.25
, Issue.6
, pp. 1105-1187
-
-
Mancia, G.1
De Backer, G.2
Dominiczak, A.3
Cifkova, R.4
Fagard, R.5
Germano, G.6
Grassi, G.7
Heagerty, A.M.8
Kjeldsen, S.E.9
Laurent, S.10
Narkiewicz, K.11
Ruilope, L.12
Rynkiewicz, A.13
Schmieder, R.E.14
Boudier, H.A.J.S.15
Zanchetti, A.16
-
33
-
-
77649091668
-
American Association of clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus
-
Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl 1):1-68
-
(2007)
Endocr Pract
, vol.13
, Issue.SUPPL. 1
, pp. 1-68
-
-
Rodbard, H.W.1
Blonde, L.2
Braithwaite, S.S.3
-
34
-
-
63849238764
-
Diagnosis and management of prediabetes in the continuum of hyperglycemia: When do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists
-
Garber AJ, Handelsman Y, Einhorn D, et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract 2008;14:933-946
-
(2008)
Endocr Pract
, vol.14
, pp. 933-946
-
-
Garber, A.J.1
Handelsman, Y.2
Einhorn, D.3
-
35
-
-
59349091844
-
Risk factor assessment for new onset diabetes: Literature review
-
Bakris G, Stockert J, Molitch M, et al. Risk factor assessment for new onset diabetes: literature review. Diabetes Obes Metab 2009;11:177-187
-
(2009)
Diabetes Obes Metab
, vol.11
, pp. 177-187
-
-
Bakris, G.1
Stockert, J.2
Molitch, M.3
-
36
-
-
38949084591
-
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
Black HR, Davis B, Barzilay J, et al. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care 2008;31:353-360
-
(2008)
Diabetes Care
, vol.31
, pp. 353-360
-
-
Black, H.R.1
Davis, B.2
Barzilay, J.3
-
37
-
-
24644443331
-
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial
-
Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906
-
(2005)
Lancet
, vol.366
, pp. 895-906
-
-
Dahlof, B.1
Sever, P.S.2
Poulter, N.R.3
-
38
-
-
48649106720
-
Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm and the relative influence of antihypertensive medication
-
Gupta AK, Dahlof B, Dobson J, et al. Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm and the relative influence of antihypertensive medication. Diabetes Care 2008;31:982-988
-
(2008)
Diabetes Care
, vol.31
, pp. 982-988
-
-
Gupta, A.K.1
Dahlof, B.2
Dobson, J.3
-
39
-
-
7744237066
-
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial
-
Bakris GL, Fonseca V, Katholi RE, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 2004;292:2227-2236
-
(2004)
JAMA
, vol.292
, pp. 2227-2236
-
-
Bakris, G.L.1
Fonseca, V.2
Katholi, R.E.3
-
40
-
-
42049107348
-
Telmisartan, ramipril, or both in patients at high risk for vascular events
-
Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547-1559
-
(2008)
N Engl J Med
, vol.358
, pp. 1547-1559
-
-
Yusuf, S.1
Teo, K.K.2
Pogue, J.3
-
41
-
-
57849090023
-
Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome
-
Zappe DH, Sowers JR, Hsueh WA, et al. Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome. J Clin Hypertens (Greenwich) 2008;10:894-903
-
(2008)
J Clin Hypertens (Greenwich)
, vol.10
, pp. 894-903
-
-
Zappe, D.H.1
Sowers, J.R.2
Hsueh, W.A.3
-
42
-
-
36248942124
-
Epidemiology and unmet need in hypertension
-
Flack JM. Epidemiology and unmet need in hypertension. J Manag Care Pharm 2007;13(8 Suppl S-b):S2-8
-
(2007)
J Manag Care Pharm
, vol.13
, Issue.8 SUPPL. S-B
-
-
Flack, J.M.1
-
43
-
-
55249099160
-
Improving blood pressure control: Increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial
-
White WB, Calhoun DA, Samuel R, et al. Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? The valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial. J Clin Hypertens (Greenwich) 2008;10:450-458
-
(2008)
J Clin Hypertens (Greenwich)
, vol.10
, pp. 450-458
-
-
White, W.B.1
Calhoun, D.A.2
Samuel, R.3
-
44
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
DOI 10.1016/S0140-6736(02)08089-3
-
Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003 (Pubitemid 34286536)
-
(2002)
Lancet
, vol.359
, Issue.9311
, pp. 995-1003
-
-
Dahlof, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
Julius, S.4
Beevers, G.5
De Faire, U.6
Fyhrquist, F.7
Ibsen, H.8
Kristiansson, K.9
Lederballe-Pedersen, O.10
Lindholm, L.H.11
Nieminen, M.S.12
Omvik, P.13
Oparil, S.14
Wedel, H.15
-
45
-
-
7744231805
-
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: The CAMELOT study:A randomized controlled trial
-
Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study:a randomized controlled trial. JAMA 2004;292:2217-2225
-
(2004)
JAMA
, vol.292
, pp. 2217-2225
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Libby, P.3
-
46
-
-
34250005878
-
Nitric oxide mechanisms in the pathogenesis of global risk
-
Mason RP. Nitric oxide mechanisms in the pathogenesis of global risk. J Clin Hypertens (Greenwich) 2006;8(8 Suppl 2):31-38
-
(2006)
J Clin Hypertens (Greenwich)
, vol.8
, Issue.8 SUPPL. 2
, pp. 31-38
-
-
Mason, R.P.1
-
47
-
-
52449127123
-
Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease
-
Mizuno Y, Jacob RF, Mason RP. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease. Am J Hypertens 2008;21:1076-1085
-
(2008)
Am J Hypertens
, vol.21
, pp. 1076-1085
-
-
Mizuno, Y.1
Jacob, R.F.2
Mason, R.P.3
-
48
-
-
34447109035
-
Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension
-
Philipp T, Smith TR, Glazer R, et al. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007;29:563-580
-
(2007)
Clin Ther
, vol.29
, pp. 563-580
-
-
Philipp, T.1
Smith, T.R.2
Glazer, R.3
-
49
-
-
33747382766
-
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
-
Leenen FH, Nwachuku CE, Black HR, et al. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension 2006;48:374-384
-
(2006)
Hypertension
, vol.48
, pp. 374-384
-
-
Leenen, F.H.1
Nwachuku, C.E.2
Black, H.R.3
-
50
-
-
0037429639
-
Management of high blood pressure in African Americans: Consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks
-
Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003;163:525-541
-
(2003)
Arch Intern Med
, vol.163
, pp. 525-541
-
-
Douglas, J.G.1
Bakris, G.L.2
Epstein, M.3
-
51
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-869
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
-
52
-
-
67649855145
-
Triple fixed-dose combination therapy: Back to the past
-
Black HR. Triple fixed-dose combination therapy: back to the past. Hypertension 2009;54:19-22
-
(2009)
Hypertension
, vol.54
, pp. 19-22
-
-
Black, H.R.1
-
53
-
-
64849106873
-
A simplified approach to the treatment of uncomplicated hypertension: A cluster randomized, controlled trial
-
Feldman RD, Zou GY, Vandervoort MK, et al. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 2009;53:646-653
-
(2009)
Hypertension
, vol.53
, pp. 646-653
-
-
Feldman, R.D.1
Zou, G.Y.2
Vandervoort, M.K.3
-
54
-
-
64849103457
-
Fixed-dose combinations and hypertension control in community-based practices: Application of the 'keep-it-simple' principle
-
Egan BM. Fixed-dose combinations and hypertension control in community-based practices: application of the 'keep-it-simple' principle. Hypertension 2009;53:598-599
-
(2009)
Hypertension
, vol.53
, pp. 598-599
-
-
Egan, B.M.1
-
55
-
-
43549108344
-
Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: The Exforge in Failure after Single Therapy (EX-FAST) study
-
Allemann Y, Fraile B, Lambert M, et al. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study. J Clin Hypertens (Greenwich) 2008;10:185-194
-
(2008)
J Clin Hypertens (Greenwich)
, vol.10
, pp. 185-194
-
-
Allemann, Y.1
Fraile, B.2
Lambert, M.3
-
56
-
-
84925560559
-
Efficacy of amlodipine/valsartan/ hydrochlorothiazide triple combination in patients whose blood pressure was not controlled with dual combinations: The PROMPT extension study
-
Presented at 6 - 9 May 2009; San Francisco, CA
-
Zappe DH, Crikelair N, Papst CC, et al. Efficacy of amlodipine/valsartan/ hydrochlorothiazide triple combination in patients whose blood pressure was not controlled with dual combinations: the PROMPT extension study. Presented at: American Society of Hypertension, 24th Annual Scientific Meeting and Exposition; 6 - 9 May 2009; San Francisco, CA
-
American Society of Hypertension, 24th Annual Scientific Meeting and Exposition
-
-
Zappe, D.H.1
Crikelair, N.2
Papst, C.C.3
-
57
-
-
3442882539
-
Use of an olmesartan medoxomil-based treatment algorithm for hypertension control
-
Neutel JM, Smith DH, Weber MA, et al. Use of an olmesartan medoxomil-based treatment algorithm for hypertension control. J Clin Hypertens (Greenwich) 2004;6:168-174
-
(2004)
J Clin Hypertens (Greenwich)
, vol.6
, pp. 168-174
-
-
Neutel, J.M.1
Smith, D.H.2
Weber, M.A.3
-
58
-
-
33645089450
-
Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension
-
Neutel JM, Smith DH, Silfani TN, et al. Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension. J Hum Hypertens 2006;20:255-262
-
(2006)
J Hum Hypertens
, vol.20
, pp. 255-262
-
-
Neutel, J.M.1
Smith, D.H.2
Silfani, T.N.3
-
59
-
-
55949102080
-
Based treatment algorithm for essencial hypertension with olmesartan medoxomil
-
Gomes MA, Feitosa AD, Oigman W, et al. Based treatment algorithm for essencial hypertension with olmesartan medoxomil. Arq Bras Cardiol 2008;91:168-193
-
(2008)
Arq Bras Cardiol
, vol.91
, pp. 168-193
-
-
Gomes, M.A.1
Feitosa, A.D.2
Oigman, W.3
-
60
-
-
67549119235
-
Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: An open-label, long-term study
-
Volpe M, Miele C, Haag U. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study. Clin Drug Investig 2009;29:381-391
-
(2009)
Clin Drug Investig
, vol.29
, pp. 381-391
-
-
Volpe, M.1
Miele, C.2
Haag, U.3
-
61
-
-
78649326084
-
Long-term efficacy of a combination of amlodipine and olmesartan medoxomil+/-hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: A substudy of the COACH trial
-
[Epub ahead of print]
-
Oparil S, Chrysant SG, Melino M, et al. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil+/-hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial. J Hum Hypertens March 4, 2010. [Epub ahead of print]
-
(2010)
J Hum Hypertens March
, vol.4
-
-
Oparil, S.1
Chrysant, S.G.2
Melino, M.3
-
62
-
-
70349973807
-
Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension
-
Chrysant SG, Oparil S, Melino M, et al. Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension. J Clin Hypertens (Greenwich) 2009;11:475-482
-
(2009)
J Clin Hypertens (Greenwich)
, vol.11
, pp. 475-482
-
-
Chrysant, S.G.1
Oparil, S.2
Melino, M.3
-
63
-
-
67649848168
-
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: A randomized clinical trial
-
Calhoun DA, Lacourciere Y, Chiang YT, Glazer RD. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial. Hypertension 2009;54:32-39
-
(2009)
Hypertension
, vol.54
, pp. 32-39
-
-
Calhoun, D.A.1
Lacourciere, Y.2
Chiang, Y.T.3
Glazer, R.D.4
-
64
-
-
84925567020
-
Effect of age, gender, race and ethnicity on efficacy of amlodipine/valsartan/ hydrochlorothiazide triple combination therapy in patients with moderate to severe hypertension
-
Presented at 6 - 9 May 2009; San Francisco, CA
-
Calhoun D, Glazer R, Yen J, et al. Effect of age, gender, race and ethnicity on efficacy of amlodipine/valsartan/ hydrochlorothiazide triple combination therapy in patients with moderate to severe hypertension. Presented at: American Society of Hypertension, 24th Annual Scientific Meeting and Exposition; 6 - 9 May 2009; San Francisco, CA
-
American Society of Hypertension, 24th Annual Scientific Meeting and Exposition
-
-
Calhoun, D.1
Glazer, R.2
Yen, J.3
-
65
-
-
84925567019
-
Effect of baseline systolic blood pressure on response to triple combination amlodipine/valsartan/ hydrochlorothiazide in patients with moderate-to-severe hypertension
-
Presented at 6 - 9 May 2009; San Francisco, CA
-
Lacourciere Y, Glazer R, Crikelair N, et al. Effect of baseline systolic blood pressure on response to triple combination amlodipine/valsartan/ hydrochlorothiazide in patients with moderate-to-severe hypertension. Presented at: American Society of Hypertension, 24th Annual Scientific Meeting and Exposition; 6 - 9 May 2009; San Francisco, CA
-
American Society of Hypertension, 24th Annual Scientific Meeting and Exposition
-
-
Lacourciere, Y.1
Glazer, R.2
Crikelair, N.3
-
66
-
-
84925569599
-
Efficacy and safety of combination olmesartan medoxomil (OM) +amlodipine besylate (AML) hydrochlorothiazide (HCTZ) in patients with hypertension: The Trinity study [abstract PO-57]
-
Oparil S, Melino M, Fernandez V, et al. Efficacy and safety of combination olmesartan medoxomil (OM) +amlodipine besylate (AML) ?hydrochlorothiazide (HCTZ) in patients with hypertension: the Trinity study [abstract PO-57]. J Clin Hypertens 2010;12(Suppl 1):A42
-
(2010)
J Clin Hypertens
, vol.12
, Issue.SUPPL. 1
-
-
Oparil, S.1
Melino, M.2
Fernandez, V.3
-
67
-
-
77954809153
-
Safety and tolerability of combination olmesartan medoxomil (OM)+amlodipine besylate (AML)+hydrochlorothiazide (HCTZ) in patients with hypertension [abstract PO-31]
-
Chrysant SG, Oparil S, Melino M, et al. Safety and tolerability of combination olmesartan medoxomil (OM)+amlodipine besylate (AML) +hydrochlorothiazide (HCTZ) in patients with hypertension [abstract PO-31]. J Clin Hypertens 2010;12(Suppl 1):A31
-
(2010)
J Clin Hypertens
, vol.12
, Issue.SUPPL. 1
-
-
Chrysant, S.G.1
Oparil, S.2
Melino, M.3
-
68
-
-
77954800882
-
Twenty-four hour efficacy and safety of full-dose, triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide [abstract PO-39]
-
Izzo J, Melino M, Fernandez V, et al. Twenty-four hour efficacy and safety of full-dose, triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide [abstract PO-39]. J Clin Hypertens 2010;12(Suppl 1):A34-5
-
(2010)
J Clin Hypertens
, vol.12
, Issue.SUPPL. 1
-
-
Izzo, J.1
Melino, M.2
Fernandez, V.3
-
69
-
-
77954809153
-
Efficacy and safety of combination olmesartan medoxomil (OM)+amlodipine besylate (AML)+hydrochlorothiazide (HCTZ) in patients with hypertension: Analysis by age and gender [abstract PO-30]
-
Chrysant SG, Melino M, Fernandez V, et al. Efficacy and safety of combination olmesartan medoxomil (OM)+amlodipine besylate (AML) +hydrochlorothiazide (HCTZ) in patients with hypertension: analysis by age and gender [abstract PO-30]. J Clin Hypertens 2010;12(Suppl 1):A30-1
-
(2010)
J Clin Hypertens
, vol.12
, Issue.SUPPL. 1
-
-
Chrysant, S.G.1
Melino, M.2
Fernandez, V.3
-
70
-
-
77954770663
-
Efficacy and safety of combination olmesartan medoxomil (OM)+amlodipine besylate (AML)+hydrochlorothiazide (HCTZ)-The Trinity study: A subgroup analysis by race [abstract PO-50]
-
Littlejohn T, Toth P, Melino M, et al. Efficacy and safety of combination olmesartan medoxomil (OM)+amlodipine besylate (AML)+hydrochlorothiazide (HCTZ)-the Trinity study: a subgroup analysis by race [abstract PO-50]. J Clin Hypertens 2010;12(Suppl 1):A39
-
(2010)
J Clin Hypertens
, vol.12
, Issue.SUPPL. 1
-
-
Littlejohn, T.1
Toth, P.2
Melino, M.3
-
71
-
-
77954794949
-
Efficacy and safety of combination olmesartan medoxomil (OM)+amlodipine besylate (AML)+hydrochlorothiazide (HCTZ) based on severity of hypertension: The Trinity study [abstract PO-45]
-
Kereiakes D, Chrysant SG, Melino M, et al. Efficacy and safety of combination olmesartan medoxomil (OM)+amlodipine besylate (AML) +hydrochlorothiazide (HCTZ) based on severity of hypertension: the Trinity study [abstract PO-45]. J Clin Hypertens 2010;12(Suppl 1):A37
-
(2010)
J Clin Hypertens
, vol.12
, Issue.SUPPL. 1
-
-
Kereiakes, D.1
Chrysant, S.G.2
Melino, M.3
-
72
-
-
34250179723
-
Fixed-dose combinations improve medication compliance: A meta-analysis
-
Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713-719
-
(2007)
Am J Med
, vol.120
, pp. 713-719
-
-
Bangalore, S.1
Kamalakkannan, G.2
Parkar, S.3
Messerli, F.H.4
-
73
-
-
57649135136
-
Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy
-
Hess G, Hill J, Lau H, et al. Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy. PT 2008;33:652-666
-
(2008)
PT
, vol.33
, pp. 652-666
-
-
Hess, G.1
Hill, J.2
Lau, H.3
-
74
-
-
0036189466
-
Rationale for fixed-dose combinations in the treatment of hypertension: The cycle repeats
-
Sica DA. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs 2002;62:443-462
-
(2002)
Drugs
, vol.62
, pp. 443-462
-
-
Sica, D.A.1
-
75
-
-
39749117949
-
Compliance with antihypertensive therapy in the elderly: A comparison of fixed-dose combination amlodipine/ benazepril versus component-based free-combination therapy
-
Dickson M, Plauschinat CA. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/ benazepril versus component-based free-combination therapy. Am J Cardiovasc Drugs 2008;8:45-50
-
(2008)
Am J Cardiovasc Drugs
, vol.8
, pp. 45-50
-
-
Dickson, M.1
Plauschinat, C.A.2
-
76
-
-
1542440031
-
Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy
-
Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail 2003;9:324-332
-
(2003)
Congest Heart Fail
, vol.9
, pp. 324-332
-
-
Taylor, A.A.1
Shoheiber, O.2
-
77
-
-
0026329802
-
Treating mild-to-moderate hypertension: A comparison of lisinopril-hydrochlorothiazide fixed combination with captopril and hydrochlorothiazide free combination
-
Graham RD. Treating mild-to-moderate hypertension: a comparison of lisinopril-hydrochlorothiazide fixed combination with captopril and hydrochlorothiazide free combination. J Hum Hypertens 1991;5(Suppl 2):59-60
-
(1991)
J Hum Hypertens
, vol.5
, Issue.SUPPL. 2
, pp. 59-60
-
-
Graham, R.D.1
-
78
-
-
36349021930
-
Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination
-
Schweizer J, Hilsmann U, Neumann G, et al. Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination. Curr Med Res Opin 2007;23:2877-2885
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 2877-2885
-
-
Schweizer, J.1
Hilsmann, U.2
Neumann, G.3
-
79
-
-
74949125742
-
Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: A meta-analysis
-
Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010;55:399-407
-
(2010)
Hypertension
, vol.55
, pp. 399-407
-
-
Gupta, A.K.1
Arshad, S.2
Poulter, N.R.3
-
80
-
-
0036863587
-
Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
-
Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393-404
-
(2002)
J Clin Hypertens (Greenwich)
, vol.4
, pp. 393-404
-
-
Cushman, W.C.1
Ford, C.E.2
Cutler, J.A.3
-
81
-
-
15944409988
-
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril
-
Wright JT Jr, Dunn JK, Cutler JA, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 2005;293:1595-1608
-
(2005)
JAMA
, vol.293
, pp. 1595-1608
-
-
Wright Jr., J.T.1
Dunn, J.K.2
Cutler, J.A.3
-
82
-
-
0345492460
-
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial
-
Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003;290:2805-2816
-
(2003)
JAMA
, vol.290
, pp. 2805-2816
-
-
Pepine, C.J.1
Handberg, E.M.2
Cooper-Dehoff, R.M.3
-
83
-
-
0037851836
-
Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial
-
Black HR, Elliott WJ, Grandits G, et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003;289:2073-2082
-
(2003)
JAMA
, vol.289
, pp. 2073-2082
-
-
Black, H.R.1
Elliott, W.J.2
Grandits, G.3
|